To hear about similar clinical trials, please enter your email below
Trial Title:
Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors
NCT ID:
NCT05525299
Condition:
Existential Suffering
Meaning of Life
Cognitive Function
Psychological Distress
Social Support
Conditions: Official terms:
Stress, Psychological
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
Single (Outcomes Assessor)
Intervention:
Intervention type:
Behavioral
Intervention name:
Reminiscence-Based Life Review
Description:
The reminiscence chatting activities covering 6 themes include:
Week 1: "Instruction of the 'Life Story Narrative Journal' and My 'Childhood' memories"
Week 2: "My 'Adolesces' memories and Memorable moments spent with my family" Week 3: "My
'Adulthood' memories and My very first full time job" Week 4: "My thoughts when I
received my cancer diagnosis" Week 5: "My favourite activities before and after receiving
a cancer diagnosis" Week 6: "When COVID-19 hits, _____ changes and The story goes on! The
future pages are more to come!"
A 'Life Story Narrative Journal' with six themes to recall subjects' memory through the
life review reminiscence activities will be given. The Life Story Narrative Journal is a
diary booklet that enables the participant to write down and express their thoughts in a
narrative.
Arm group label:
Intervention
Summary:
Target Issue:
Cognitive impairment in older cancer survivors is highly prevalent and the co-existing
neuro-psychiatric symptoms, particularly depression, would further complicate the
psychosocial consequence of existential suffering. However, no reminiscence-based
interventions are specifically developed for older people with cancer have been developed
and evaluated.
Target Population:
Cancer survivors aged 65 years old and above with a mild cognitive impairment identified
by the HK-MoCA 5-Min Protocol cognitive assessment.
Intervention:
This research project aims to implement a brief reminiscence-based intervention that
includes six reminiscence chatting sessions among older cancer survivors. The proposed
reminiscence-based intervention has great potential to provide psychological and
spiritual care as well as comfort to those who are weak, aged and are in need of
assistance.
Study Objectives:
1. To evaluate the effect of a reminiscence-based life review intervention on copying
with existential suffering including meaning of life (primary outcome), cognitive
function, psychological distress and social support (secondary outcomes) in older
cancer survivors
2. To explore older cancer survivors' experience of the intervention regarding the
impact of the intervention on their existential suffering
Study Method:
The investigator will recruit 116 voluntary elder patients from the outpatient oncology
clinics of the Queen Mary Hospital to participate in the study. They will be individually
randomized at a 1:1 ratio to receive usual care or the brief reminiscence-based
intervention at home. Outcomes will be assessed at baseline (T0), post-intervention (T1),
and 6-week follow-up (T2). A qualitative interview regarding the feedback on the
intervention will be undertaken only in the intervention group.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Aged ≥ 65 years
- Diagnosed with stage I-III non-metastatic cancer
- Completed primary treatment with curative intent (surgery, chemotherapy, and/or
radiation therapy) 6 months to 5 years prior to baseline assessments with no
recurrence or occurrence of additional cancers
- identified as mild cognitive impairment by the HK-MoCA 5-Min Protocol cognitive
assessment (≤ 7th age and education corrected percentile cutoff score)
Exclusion Criteria:
- Inadequate written and verbal Cantonese and/or English comprehension for study
activities
- Diagnosed with dementia
Gender:
All
Minimum age:
65 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
School of Nursing, The University of Hong Kong
Address:
City:
Hong Kong
Country:
Hong Kong
Status:
Recruiting
Contact:
Last name:
Mu-Hsing Ho, PhD
Phone:
+852 39102787
Email:
mhbho@hku.hk
Contact backup:
Last name:
Kelvin Chow, BSc
Phone:
+852 92186066
Email:
chowkayu@hku.hk
Investigator:
Last name:
Mu-Hsing Ho, PhD
Email:
Principal Investigator
Start date:
October 30, 2022
Completion date:
August 30, 2024
Lead sponsor:
Agency:
The University of Hong Kong
Agency class:
Other
Source:
The University of Hong Kong
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05525299
